LUCID CAPITAL MARKETS Initiates Coverage On LENSAR with Buy Rating, Announces Price Target of $11
9/28/2026
Impact: 75
Healthcare
LUCID CAPITAL MARKETS has initiated coverage on LENSAR (NASDAQ: LNSR) with a Buy rating. The firm has set a price target of $11 for the stock.
AI summary, not financial advice
Share: